Yarrow Bioscience, Inc. (YARW)

Every FINRA and SEC series the site collects for Yarrow Bioscience, Inc.: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on Nasdaq.

Download CSV

56K

Short interest

settlement 2026-08-31

1.2

Days to cover

+190.8% vs prior

46.0%

Short share of volume

2026-09-17

Fails to deliver

settlement 2026-08-27

Thu 12 Aug

Next earnings

estimated; last year 2026-08-13

Insider flow, 90 days

0 buys, 0 sells

As of 2026-09-17.

Short interest

FINRA, twice a month; the last 12 months shown, all 3 settlements in the JSON

As of 31 August 2026, short interest in YARW is 56,499 shares, up 43,917 shares over the last month. At the reported average volume of 47K shares a day that is 1.2 days to cover.

Settlement	Shares short	Change	Avg daily volume	Days to cover
2026-08-31	56,499	+190.8%	46,917	1.20
2026-08-14	19,427	+54.4%	17,382	1.12
2026-07-31	12,582	-93.2%	38,657	1.00

Daily short volume

FINRA Reg SHO, last 37 sessions. JSON

As of 17 September 2026, the short share of YARW volume is 46.0%, down 18.2 points over the last five sessions. Over the last 37 readings it ranged from 2.5% (24 August 2026) to 90.0% (26 August 2026). The latest reading is 11.8 points below the 30-session average of 57.7%, on 56K shares reported.

Date	Short volume	Total volume	Short share	Exempt
2026-09-17	26K	56K	46.0%	0
2026-09-16	13K	23K	55.6%	0
2026-09-15	11K	40K	26.7%	0
2026-09-14	17K	29K	60.1%	0
2026-09-11	39K	449K	8.6%	101
2026-09-10	6K	9K	64.2%	12
2026-09-09	5K	8K	58.4%	3
2026-09-08	6K	11K	54.2%	0
2026-09-04	7K	10K	74.2%	0
2026-09-03	2K	7K	31.8%	0
2026-09-02	5K	8K	60.5%	0
2026-09-01	4K	8K	45.3%	0
2026-08-31	10K	18K	54.7%	164
2026-08-28	10K	13K	73.8%	0
2026-08-27	6K	10K	57.5%	0
2026-08-26	7K	7K	90.0%	0
2026-08-25	689	1K	55.7%	0
2026-08-24	4K	179K	2.5%	0
2026-08-21	3K	5K	57.6%	0
2026-08-20	13K	15K	86.6%	0
2026-08-19	13K	15K	85.0%	0
2026-08-18	7K	9K	86.3%	0
2026-08-17	6K	8K	78.0%	0
2026-08-14	850	1K	77.7%	0
2026-08-13	3K	6K	56.0%	0
2026-08-12	2K	5K	45.7%	0
2026-08-11	1K	2K	53.8%	0
2026-08-10	5K	8K	55.3%	0
2026-08-07	8K	12K	64.7%	0
2026-08-06	6K	9K	65.6%	0

Fails to deliver

SEC, by settlement date. JSON

As of 27 August 2026, the fails-to-deliver balance in YARW is 66 shares, up 62 shares over the last settlement date. Over the last 9 readings it ranged from 1 share (3 August 2026) to 1,095 shares (6 August 2026). The latest reading sits at the bottom of that range.

Settlement	Shares failed	Price	Value
2026-08-27	66	$38.87	$3K
2026-08-20	4	$40.60	$162
2026-08-06	1,095	$37.70	$41K
2026-08-05	2	$37.96	$76
2026-08-04	1	$33.59	$34
2026-08-03	1	$35.02	$35
2026-07-31	7	$32.99	$231
2026-07-30	44	$30.45	$1K
2026-07-29	755	$28.05	$21K

Insider trades

SEC Form 4, newest first. JSON

No open-market insider trades were reported for YARW in the last 90 days. The most recent filings are listed below; grants and option exercises carry a weaker signal than voluntary trades. Latest filing: RTW Fund Group GP, LLC on 2026-07-29.

Date	Insider	Title	Type	Shares	Price	Value	Owned after
2026-07-29	RTW Fund Group GP, LLC	n/a	J	133K	$0.00	$0	266K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.

Large holders (13D and 13G)

One row per reporting person, newest filing first. JSON

39 holders above 5% have filed on YARW, 8 on Schedule 13D (active intent). The largest reported stake is Logos Global Management LP at 10.7% of the class (286,308 shares), filed 2026-08-07 for an event on 2026-07-31.

Filed	Form	Holder	Shares	Of class	Event
2026-09-17	13G	Raymond Debbaneindividual	675K	7.2%	2026-09-11
2026-09-17	13G	Invus Public Equities, L.P.partnership	591K	6.3%	2026-09-11
2026-09-17	13G	Siren, L.L.C.other entity	591K	6.3%	2026-09-11
2026-09-17	13G	Invus Global Management, LLCother entity	591K	6.3%	2026-09-11
2026-09-17	13G	Invus Public Equities Advisors, LLCother entity	591K	6.3%	2026-09-11
2026-09-17	13G	Ulys, L.L.C.other entity	84K	0.9%	2026-09-11
2026-09-17	13G	Avicenna Life Sci Master GP LLCother entity	84K	0.9%	2026-09-11
2026-09-17	13G	Avicenna Life Sci Master Fund LPpartnership	84K	0.9%	2026-09-11
2026-08-14	13G	venBio Global Strategic GP V, LLCparent holding company, other entity	279K	10.0%	2026-07-27
2026-08-14	13G	venBio Global Strategic Fund V, L.P.partnership	279K	10.0%	2026-07-27
2026-08-14	13G	ADAR1 Capital Management, LLCinvestment adviser, other entity	59K	8.8%	2026-06-30
2026-08-14	13G	Daniel Schneebergerparent holding company, individual	59K	8.8%	2026-06-30
2026-08-13	13G/Ano. 3	Zhang Xiaofanindividual	162K	0.6%	2026-08-13
2026-08-07	13G/Ano. 1	Logos Global Management LPinvestment adviser, partnership	286K	10.7%	2026-07-31
2026-08-07	13G/Ano. 1	Arsani Williamparent holding company, individual	286K	10.7%	2026-07-31
2026-08-07	13G/Ano. 1	Logos Global Management GP LLCparent holding company, other entity	286K	10.7%	2026-07-31
2026-08-07	13G	JANUS HENDERSON GROUP Ltd.parent holding company	267K	10.0%	2026-07-31
2026-08-07	13G/Ano. 1	Logos Global Master Fund LPpartnership	177K	6.6%	2026-07-31
2026-08-07	13G/Ano. 1	Logos GP LLCparent holding company, other entity	177K	6.6%	2026-07-31
2026-08-07	13G/Ano. 1	Graham Walmsleyparent holding company, individual	110K	4.1%	2026-07-31
2026-08-07	13G/Ano. 1	Logos Opportunities Fund V LPpartnership	110K	4.1%	2026-07-31
2026-08-07	13G/Ano. 1	Logos Opportunities V GP LLCparent holding company, other entity	110K	4.1%	2026-07-31
2026-08-05	13D	ORBIMED ADVISORS LLCinvestment adviser	266K	10.0%	2026-07-27
2026-08-05	13D	OrbiMed Capital GP X LLCother entity	233K	8.7%	2026-07-27
2026-08-05	13D	OrbiMed Capital GP X, LPother entity	233K	8.7%	2026-07-27
2026-08-05	13D	OrbiMed Genesis GP LLCother entity	33K	1.3%	2026-07-27
2026-08-04	13G	Logos Global Management GP LLCparent holding company, other entity	277K	9.9%	2026-07-27
2026-08-04	13G	Logos Global Management LPinvestment adviser, partnership	277K	9.9%	2026-07-27
2026-08-04	13G	Logos Opportunities V GP LLCparent holding company, other entity	257K	9.9%	2026-07-27
2026-08-04	13G	Logos Opportunities Fund V LPpartnership	257K	9.9%	2026-07-27
2026-08-04	13G	Logos GP LLCparent holding company, other entity	120K	9.9%	2026-07-27
2026-08-04	13G	Logos Global Master Fund LPpartnership	120K	9.9%	2026-07-27
2026-08-04	13G	Arsani Williamparent holding company, individual	277K	9.9%	2026-07-27
2026-08-04	13G	Graham Walmsleyparent holding company, individual	257K	9.9%	2026-07-27
2026-08-03	13G	Joseph Edelmanindividual	267K	10.0%	2026-07-27
2026-08-03	13G	Perceptive Life Sciences Master Fund, Ltd.corporation	267K	10.0%	2026-07-27
2026-08-03	13G	Perceptive Advisors LLCinvestment adviser	267K	10.0%	2026-07-27
2026-07-30	13G	Roderick Wongparent holding company, individual	266K	10.0%	2026-07-27
2026-07-30	13G	RTW Fund Group GP, LLCinvestment adviser, parent holding company	266K	10.0%	2026-07-27
2026-07-29	13D/Ano. 1	Access Industries Management, LLCother entity	178K	6.0%	2026-07-27
2026-07-29	13D/Ano. 1	Len Blavatnikindividual	178K	6.0%	2026-07-27
2026-07-29	13D/Ano. 1	AI Biotechnology LLCother entity	178K	6.0%	2026-07-27
2026-07-29	13D/Ano. 1	Access Industries Holdings LLCother entity	178K	6.0%	2026-07-27
2026-07-17	13G/Ano. 2	Zhang Xiaofan	n/a	n/a	2026-06-08
2026-07-14	13G/Ano. 1	Zhang Xiaofan	n/a	n/a	2026-07-13
2026-06-15	13G	Zhang Xiaofanindividual	1.9M	5.6%	2026-06-08
2026-05-15	13G	Nantahala Capital Management, LLCinvestment adviser	2.0M	6.0%	2026-03-31
2026-05-15	13G	Wilmot B. Harkeyparent holding company	2.0M	6.0%	2026-03-31
2026-05-15	13G	Daniel Mackparent holding company	2.0M	6.0%	2026-03-31
2025-11-14	13G/Ano. 3	Citadel Advisors Holdings LPparent holding company, partnership	4K	0.0%	2025-09-30

What this page is

Yarrow Bioscience, Inc. in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.

This page follows Yarrow Bioscience, Inc. (YARW), SEC CIK 1566044, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.

Source and method

Short interest: FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-31.JSON and CSV
Daily short volume: FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-17.JSON and CSV
Fails to deliver: SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-27.JSON and CSV
Large holders: SEC EDGAR Schedule 13D and 13GEDGAR read every 30 minutes; 13D within five business days of crossing 5%, 13G on the passive schedule. Latest 2026-09-17.JSON and CSV
Earnings dates: SEC EDGAR 8-K Item 2.02 (full-text search)EDGAR full-text search read twice a day; the estimate is last year's date plus 52 weeks. Latest 2026-08-13.JSON and CSV
Insider trades: SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-07-29.JSON and CSV
Company record: EDGAR filing index for CIK 1566044Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits: 30 requests a minute without a key, 120 a minute with a key from a free account.

Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 18 Sep 05:40 UTC.

How to read it

Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of YARW is sold short?

56,499 shares were held short at the 2026-08-31 settlement, 1.2 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.

What is YARW's daily short volume?

On 2026-09-17, 25,611 of the 55,683 YARW shares reported to FINRA were sold short, 46.0% of the day's reported volume. Short volume is a flow for one day, not a position.

Does YARW have fails to deliver?

The SEC's latest file shows 66 YARW shares failed to deliver at settlement 2026-08-27. Fails are reported per settlement date and published twice a month with a lag.

Are YARW insiders buying or selling?

Who owns more than 5% of YARW?

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.

Yarrow Bioscience, Inc. (YARW)

Short interest

Daily short volume

Fails to deliver

Insider trades

Large holders (13D and 13G)

Yarrow Bioscience, Inc. in the regulatory record

Source and method

How to read it

Other company pages

Datasets

Frequently Asked Questions